(Q34416590)

2 August 2017

title

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation (English)

1 reference

V-set domain containing T cell activation inhibitor 1

2 August 2017

main subject

1 reference

negative regulation of apoptotic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

Susana Salceda

1

1 reference

2 August 2017

Tenny Tang

2

1 reference

2 August 2017

Muriel Kmet

3

1 reference

2 August 2017

Andrei Munteanu

4

1 reference

2 August 2017

Malavika Ghosh

5

1 reference

2 August 2017

Roberto Macina

6

1 reference

2 August 2017

Wenhui Liu

7

1 reference

2 August 2017

Glenn Pilkington

8

1 reference

2 August 2017

Jackie Papkoff

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Experimental Cell Research

2 August 2017

published in

1 reference

2 August 2017

volume

306

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

128-141

1 reference

New targeted therapies in breast cancer

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Novel systemic therapies for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Survival of patients with epithelial ovarian cancer and the effect of lymphadenectomy in those with stage 3 disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

7 January 2021

Carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

The roles of the new negative T cell costimulatory pathways in regulating autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

B7x: a widely expressed B7 family member that inhibits T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

B7S1, a novel B7 family member that negatively regulates T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

B7-h4 is highly expressed in ductal and lobular breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Controlling apoptosis by inhibition of caspases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Apoptosis: biochemical aspects and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Protection against anoikis and down-regulation of cadherin expression by a regulatable beta-catenin protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Regulation of epithelial cell migration and tumor formation by beta-catenin signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Oncogenic pathways implicated in ovarian epithelial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Immunology of B7-H1 and its roles in human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.01.018

10.1016/J.YEXCR.2005.01.018

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference